HomeCompareHOLX vs HES

HOLX vs HES: Dividend Comparison 2026

HOLX yields 2.65% · HES yields 1.34%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HES wins by $852.6K in total portfolio value· pulled ahead in Year 2
10 years
HOLX
HOLX
● Live price
2.65%
Share price
$75.55
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.6K
Annual income
$314.03
Full HOLX calculator →
HES
HES
● Live price
1.34%
Share price
$148.97
Annual div
$2.00
5Y div CAGR
79.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$876.2K
Annual income
$619,272.65
Full HES calculator →

Portfolio growth — HOLX vs HES

📍 HES pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHOLXHES
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HOLX + HES cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HOLX pays
HES pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HOLX
Annual income on $10K today (after 15% tax)
$225.02/yr
After 10yr DRIP, annual income (after tax)
$266.93/yr
HES
Annual income on $10K today (after 15% tax)
$114.12/yr
After 10yr DRIP, annual income (after tax)
$526,381.75/yr
At 15% tax rate, HES beats the other by $526,114.83/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HOLX + HES for your $10,000?

HOLX: 50%HES: 50%
100% HES50/50100% HOLX
Portfolio after 10yr
$449.9K
Annual income
$309,793.33/yr
Blended yield
68.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on HES right now

HOLX
Analyst Ratings
18
Buy
23
Hold
1
Sell
Consensus: Hold
Price Target
$77.80
+3.0% upside vs current
Range: $76.00 — $79.00
Altman Z
4.2
Piotroski
7/9
HES
Analyst Ratings
18
Buy
30
Hold
Consensus: Hold
Price Target
$148.19
-0.5% upside vs current
Range: $86.00 — $199.00
Altman Z
3.1
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HOLX buys
0
HES buys
0
No recent congressional trades found for HOLX or HES in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHOLXHES
Forward yield2.65%1.34%
Annual dividend / share$2.00$2.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%79.8%
Portfolio after 10y$23.6K$876.2K
Annual income after 10y$314.03$619,272.65
Total dividends collected$2.9K$831.8K
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusHoldHold
Analyst price target$77.80$148.19

Year-by-year: HOLX vs HES ($10,000, DRIP)

YearHOLX PortfolioHOLX Income/yrHES PortfolioHES Income/yrGap
1$10,965$264.73$10,941$241.39+$24.00HOLX
2← crossover$12,004$271.27$12,151$443.81$147.00HES
3$13,121$277.55$13,830$828.22$709.00HES
4$14,323$283.54$16,382$1,584.01$2.1KHES
5$15,615$289.27$20,682$3,152.91$5.1KHES
6$17,003$294.73$28,818$6,688.61$11.8KHES
7$18,493$299.93$46,496$15,661.01$28.0KHES
8$20,093$304.87$92,211$42,460.02$72.1KHES
9$21,809$309.57$240,164$141,498.19$218.4KHES
10$23,649$314.03$876,248$619,272.65$852.6KHES

HOLX vs HES: Complete Analysis 2026

HOLXHealthcare

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Full HOLX Calculator →

HESStock

Hess Corporation, an exploration and production company, explores, develops, produces, purchases, transports, and sells crude oil, natural gas liquids (NGLs), and natural gas. The company operates in two segments, Exploration and Production, and Midstream. It conducts production operations primarily in the United States, Guyana, the Malaysia/Thailand Joint Development Area, and Malaysia; and exploration activities principally offshore Guyana, the U.S. Gulf of Mexico, and offshore Suriname and Canada. The company is also involved in gathering, compressing, and processing natural gas; fractionating NGLs; gathering, terminaling, loading, and transporting crude oil and NGL through rail car; and storing and terminaling propane, as well as providing water handling services primarily in the Bakken Shale plays in the Williston Basin area of North Dakota. As of December 31, 2021, it had total proved reserves of 1,309 million barrels of oil equivalent. The company was incorporated in 1920 and is headquartered in New York, New York.

Full HES Calculator →
📬

Get this HOLX vs HES comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HOLX vs SCHDHOLX vs JEPIHOLX vs OHOLX vs KOHOLX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.